Need Help? Chat Now With a Live Representative!

Press Release: ARG Opens New European Offices

Press Release: ARG Opens New European Offices

Press Release: ARG Opens New European Offices

August 27, 2019

CHARLOTTESVILLE, Va., WARSAW, Poland, and AMSTERDAM, August 27, 2019—Atlantic

Research Group (ARG), a full-service global contract research organization (CRO), has opened new European offices in Amsterdam and Warsaw. The corporate offices, combined with an existing London location, strengthen ARG’s global operations and set the stage for continued growth.

ARG now offers comprehensive clinical development within the United Kingdom, Western Europe, and Central and Eastern Europe, company executives say. An industry leader in clinical trial management in oncology, immunology, rare and neurodegenerative disease, ARG was founded in 2004.

ARG has managed clinical studies in The Netherlands and Poland since 2006. By opening offices in Amsterdam and Warsaw, ARG will significantly strengthen its reach across Europe and enhance its capability to better serve small to mid-sized biotech companies.

“The new offices are the natural next steps in our controlled growth. We are excited by the cities’ well-established healthcare systems, central locations, and solid overall infrastructure,” Paul Bishop, CEO and cofounder said. “We can better serve Sponsors with facilitated access to new patients and sites.”

Ignazio Di Giovanna, Vice-President of European Operations, added: “The timing could not be better for ARG. Opening these offices means that we are prepared for any Brexit implications in the near term. And looking to the future, these excellent locations will become gateways for regulatory guidance and organizational growth. The Amsterdam office provides us proximity to the European Medicines Agency’s new home and our Warsaw office will enable us to capitalize on Poland’s very impressive talent pool.”

Please download a PDF of the release here: ARG opens European offices.

Contact: Casey LoFrese,
ARG Marketing Manager
+1 (434) 485-5886
clofrese@atlanticresearchgroup.com

Breaking Ground in Medicine: Our Role in the Approval of Bivigam by ADMA Biologics

Breaking Ground in Medicine: Our Role in the Approval of Bivigam by ADMA Biologics

Since 2004, ARG has been working in the immunology space, using our individualized approach to optimize the likelihood of successful […]

March 8, 2024
ARG and Humacyte Collaborate on Human Acellular Vessel (HAV) Program Advancements in Vascular Trauma

ARG and Humacyte Collaborate on Human Acellular Vessel (HAV) Program Advancements in Vascular Trauma

CHARLOTTESVILLE, VIRGINIA – ARG (Atlantic Research Group) proudly announces its ongoing collaboration with Humacyte, a leading biotechnology company, on the […]

February 23, 2024
Revolutionizing Treatment: Our Contribution to Humacyte’s Latest Innovation

Revolutionizing Treatment: Our Contribution to Humacyte’s Latest Innovation

In 2014, ARG began working with Humacyte on their Human Acellular Vessel (HAV) interposition graft program, which included three separate […]

February 7, 2024
GO TO TOP